Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Consolidated Net Income (2020 - 2025)

Historic Consolidated Net Income for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $3.8 million.

  • IceCure Medical's Consolidated Net Income fell 1064.52% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 560.13%. This contributed to the annual value of $15.7 million for FY2024, which is 77.04% up from last year.
  • IceCure Medical's Consolidated Net Income amounted to $3.8 million in Q3 2025, which was down 1064.52% from $3.4 million recorded in Q2 2025.
  • IceCure Medical's 5-year Consolidated Net Income high stood at $4.5 million for Q4 2024, and its period low was -$29.5 million during Q4 2022.
  • Moreover, its 5-year median value for Consolidated Net Income was $3.7 million (2025), whereas its average is $806789.5.
  • In the last 5 years, IceCure Medical's Consolidated Net Income tumbled by 12976.21% in 2021 and then skyrocketed by 33379.31% in 2022.
  • Quarter analysis of 5 years shows IceCure Medical's Consolidated Net Income stood at -$16.3 million in 2021, then crashed by 81.04% to -$29.5 million in 2022, then skyrocketed by 111.56% to $3.4 million in 2023, then skyrocketed by 32.5% to $4.5 million in 2024, then fell by 15.23% to $3.8 million in 2025.
  • Its Consolidated Net Income was $3.8 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.7 million in Q1 2025.